Pure Global
NCT06274359

Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities

Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities: A Pilot Pragmatic Trial
Denver Health and Hospital Authority·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Influenza
Drug/Device/Intervention
Digital storytelling
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Denver Health and Hospital Authority
Location
Denver,Denver, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Aug 31, 2027
Enrollment
200 participants
Primary outcome

Child influenza vaccination status at influenza season's end (defined as March 31, 2025 for season 1 and March 31, 2026 for season 2 if a 2nd season of recruitment is necessary)

Summary

While the COVID-19 pandemic has highlighted health disparities, Black children have unduly
 suffered and died from seasonal influenza for decades. Through sustained partnership with
 Black community stakeholders, novel community-engaged research methods, and an innovative
 intervention approach, this proposal will explore, develop, and test a Digital Storytelling
 intervention to reduce influenza vaccination disparities in Black children aged 6 months to 5
 years. This project will advance our understanding of engagement methods and interventions
 that improve health equity and serve as a model for future work to address vaccination
 disparities, ensuring all individuals have the chance to fulfill their potential free of
 preventable diseases.

ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06274359
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06274359 through Pure Global AI's free database. This phase not specified trial is sponsored by Denver Health and Hospital Authority and is currently Not yet recruiting. The study focuses on Influenza. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.